OTC · Medical - Pharmaceuticals

Burzynski Research Institute, Inc. (BZYR) Stock

$0.00 OTC: BZYR Healthcare

Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers.

Valuation

MetricValue
Price$0.00
Market Cap$525794
P/E Ratio-0.41
P/B Ratio-7.81
P/S Ratio0.00
EPS (TTM)$-0.01
52-Week High$0.05
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE—
ROA—
ROCE—
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.03

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-1.0M$-1.0M$-1.0M$-1.0M
Net Profit$-1.0M$-1.0M$-1.0M$-1.0M$-1.0M
EPS$-0.01$-0.01$-0.01$-0.01$-0.01
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$0$0$0$0
Total Liabilities$0$0$0$0$0
Cash$0$0$0$0$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$0$-1.0M$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$1.0M$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$-1.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio-0.03
EV / EBITDA-0.41
FCF Yield-192.84%
Quick Ratio0.03
Interest Coverage0.00
Return 1Y-87.50%
Return 3Y-91.55%
Return 5Y-82.35%

Ownership

Insiders Held81.00%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BETRFBetterLife Pharma Inc. $0.15 -7.50% -16.80 $23.96M 0.00%
BIXTBioxytran, Inc. $0.02 +1.49% -0.91 $2.37M 0.00%
BVAXFBioVaxys Technology Corp. $0.11 +0.09% -0.59 $3.27M 0.00%
CPMVMosaic ImmunoEngineering Inc. $0.55 +65.36% -6.11 $3.98M 0.00%
FAMDFFutura Medical plc $0.00 — -0.15 $712597 0.00%

About Burzynski Research Institute, Inc.

Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.

Burzynski Research Institute, Inc. (BZYR) stock trades at $0.00 with a market capitalization of $525794. The stock is valued at a price-to-earnings (P/E) ratio of -0.41, price-to-book of -7.81, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.05, and currently trades 100.0% below its 52-week high.

On profitability, Burzynski Research Institute, Inc. generates an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: propcitweb.ddns.net:83

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides